SCHEMBL7784542

SCHEMBL7784542

CC(=O)OC1CCC([N]c2ccc(Cl)cc2)CC1

nearest known ligand 0.38

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.38
LMNA P02545 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
KMT2A Q03164 1/20 0.34
TP53 P04637 1/20 0.33
CHRM3 P20309 1/20 0.33
MAPT P10636 1/20 0.32
EPHX2 P34913 1/20 0.32
NPC1 O15118 1/20 0.32
SLC6A3 Q01959 1/20 0.32
SERPINE1 P05121 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28002067 0.76 HSD17B1 (0.45) SMN1; SMN2LMNAKMT2ATP53MAPT
SCHEMBL7790476 0.76 LMNA (0.46) SMN1; SMN2LMNACYP2C19KMT2AMAPT
SCHEMBL7784589 0.73 HTR3E (0.38) SMN1; SMN2LMNACYP2D6CYP2C19MAPT
SCHEMBL7784546 0.73 POLB (0.50) SMN1; SMN2LMNACYP2C19MAPTEPHX2
SCHEMBL28006794 0.71 NOTUM (0.51) SMN1; SMN2LMNACYP2C19KMT2AMAPT
SCHEMBL7793305 0.70 PDE7A (0.41) LMNACYP2D6CYP2C19MAPTNPC1
SCHEMBL177205 0.70
SCHEMBL12476221 0.70 CHRM2 (0.42) LMNACYP2D6KMT2ACHRM3SERPINE1
Ammonia Solution, Strong SCHEMBL28770241 0.68
SCHEMBL28780475 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1150963-A1 SUBSTITUTED 4-AMINO-2-ARYLTETRAHYDROQUINAZOLINES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM Aventis Pharma Deutschland GmbH (DE) 2001-11-07 EP disclosed
WO-2000046214-A1 SUBSTITUTED 4-AMINO-2-ARYLTETRAHYDROQUINAZOLINES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-08-10 WO disclosed